Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Plans To Improve REMS Effectiveness With Guidance On Goals And Metrics

18 Feb 2013

• By Cathy Dombrowski

Related Content

FDA Standardizing REMS Re-Enrollment Procedures

02 Dec 2011

PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones

05 Sep 2011

Teratogenic Drugs Pose Little Risk To Partners Of Male Patients, FDA Panel Says

14 Jan 2013

REMS Assessments Could Measure Behavior, Not Just Knowledge, Industry Tells FDA

09 Jul 2012

REMS Clock Ticking: Sponsors Grapple With Assessment Time Constraints

09 Jul 2012

Additional Topics

United States Regulation Post Market Regulation & Studies Risk Management BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.